NRID doesn't have any outside deals that pumped its stock.
It got a chance to stay in business for a little while longer, that's all. That stock had been priced for imminent bankruptcy, and now it's repriced for a brief respite.
Why would Oracle/Sun want NRID? It doesn't have any biometric core technology. It uses an API that has clearly lost out to BioAPI. It is not exactly a safe company on which to pin a corporate investment. Oracle is allied with Identix in database applications. (Yeah, I saw that "Oracle partners" link in the NRID SI post, but anyone who claims compatability in software would get listed; it's not exactly a commitment by Oracle in a PR or pilot).
For the same reasons, why would any major company want to use NRID? From a strategic standpoint, they have placed themselves in a hopeless position. From a financial standpoint, there is very little there. Why would Gateway, for example, want to OEM NRID software? I mean, for the same or less money, they can get the IDT deal, which has these advantages: (1) It's been cleared by Compaq, so we can be sure it works; (2) It comes with the actual reader; and (3) The company supplying it will still be in business in a year or two.
NRID is not competitive in biometrics. It is a software company, but doesn't offer anything others already offer, or can easily offer. And it has the wrong API. If you want to throw your money away in this field, you have any number of choices, like NRID, Mytec, DDSI, GDER, SACM . . . too many choices. |
